Literature DB >> 20299253

Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.

Richard K Tsai1, Pia L Rodriguez, Dennis E Discher.   

Abstract

Phagocytes engulf foreign cells but not 'self' in part because self cells express CD47 as a ligand for signal regulatory protein SIRPalpha, which inhibits phagocytosis. Motivated by reports of upregulation of CD47 on both normal and cancerous stem cells [1: Jaiswal et al., 2009] and also by polymorphisms in SIRPalpha [2: Takenaka et al., 2007], we show here that inhibition of engulfment correlates with affinity of CD47 for SIRPalpha - but only at low levels of CD47. One common human polymorph of SIRPalpha is studied and binds more strongly to human-CD47 than to mouse-CD47 (K(d) approximately 0.12 microM and 6.9 microM, respectively) and does not bind sheep red blood cells (RBCs) - which are well-established targets of human macrophages; in comparison, a common mouse polymorph of SIRPalpha binds with similar affinity to human and mouse CD47 (K(d) approximately 0.22 microM). Using immunoglobulin (IgG)-opsonized particles with varying levels of either human- or mouse-CD47, the effective inhibition constants K(i) for blocking phagocytosis are then determined with both human- and mouse-derived macrophages. Only human phagocytes show significant differences in man versus mouse K(i)'s and only at CD47 levels below normal densities for RBCs. While phospho-signaling through human-SIRPalpha shows similar trends, consistent again with the affinity differences, saturating levels of CD47 (>K(i)) can signal and inhibit phagocytosis regardless of man versus mouse. Quantitative analyses here prompt more complete characterizations of both CD47 levels and SIRPalpha polymorphisms when attempting to study in vivo effects of these key proteins in innate immunity. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299253      PMCID: PMC2878922          DOI: 10.1016/j.bcmd.2010.02.016

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  41 in total

1.  Rh(null) red blood cells with reduced CD47 do not show increased interactions with peripheral blood monocytes.

Authors:  Patricia A Arndt; George Garratty
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

2.  Clustering of the high affinity Fc receptor for immunoglobulin G (Fc gamma RI) results in phosphorylation of its associated gamma-chain.

Authors:  A M Duchemin; L K Ernst; C L Anderson
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

3.  A family of proteins that inhibit signalling through tyrosine kinase receptors.

Authors:  A Kharitonenkov; Z Chen; I Sures; H Wang; J Schilling; A Ullrich
Journal:  Nature       Date:  1997-03-13       Impact factor: 49.962

4.  Characterization of the autologous antibodies that opsonize erythrocytes with clustered integral membrane proteins.

Authors:  F Turrini; F Mannu; P Arese; J Yuan; P S Low
Journal:  Blood       Date:  1993-06-01       Impact factor: 22.113

5.  A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion.

Authors:  Y Fujioka; T Matozaki; T Noguchi; A Iwamatsu; T Yamao; N Takahashi; M Tsuda; T Takada; M Kasuga
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

6.  High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages.

Authors:  A Veillette; E Thibaudeau; S Latour
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

7.  Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cells.

Authors:  Kris Noel Dahl; Ranganath Parthasarathy; Connie M Westhoff; D Mark Layton; Dennis E Discher
Journal:  Blood       Date:  2003-10-09       Impact factor: 22.113

8.  Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis.

Authors:  M H Brown; A N Barclay
Journal:  Protein Eng       Date:  1994-04

9.  Functional separation of pseudopod extension and particle internalization during Fc gamma receptor-mediated phagocytosis.

Authors:  M B Lowry; A M Duchemin; J M Robinson; C L Anderson
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

10.  Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages.

Authors:  S Greenberg; P Chang; S C Silverstein
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  58 in total

1.  Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.

Authors:  Mark P Chao; Siddhartha Jaiswal; Rachel Weissman-Tsukamoto; Ash A Alizadeh; Andrew J Gentles; Jens Volkmer; Kipp Weiskopf; Stephen B Willingham; Tal Raveh; Christopher Y Park; Ravindra Majeti; Irving L Weissman
Journal:  Sci Transl Med       Date:  2010-12-22       Impact factor: 17.956

2.  CD47 in Erythrocyte Ageing and Clearance - the Dutch Point of View.

Authors:  Patrick Burger; Dirk de Korte; Timo K van den Berg; Robin van Bruggen
Journal:  Transfus Med Hemother       Date:  2012-09-06       Impact factor: 3.747

3.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

4.  A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.

Authors:  Sukhbir Kaur; Abdel G Elkahloun; Satya P Singh; Anush Arakelyan; David D Roberts
Journal:  J Cell Commun Signal       Date:  2017-11-29       Impact factor: 5.782

Review 5.  Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties.

Authors:  Nisha G Sosale; Kyle R Spinler; Cory Alvey; Dennis E Discher
Journal:  Curr Opin Immunol       Date:  2015-07-13       Impact factor: 7.486

6.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform.

Authors:  Che-Ming J Hu; Li Zhang; Santosh Aryal; Connie Cheung; Ronnie H Fang; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

Review 7.  Red blood cells as an efficient in vitro model for evaluating the efficacy of metallic nanoparticles.

Authors:  Ridhima Wadhwa; Taru Aggarwal; Noopur Thapliyal; Ashutosh Kumar; Pooja Yadav; Vandana Kumari; Boda Sai Charan Reddy; Pranjal Chandra; Pawan Kumar Maurya
Journal:  3 Biotech       Date:  2019-06-21       Impact factor: 2.406

Review 8.  Mechanisms of Immune Tolerance in Leukemia and Lymphoma.

Authors:  Emily K Curran; James Godfrey; Justin Kline
Journal:  Trends Immunol       Date:  2017-05-13       Impact factor: 16.687

9.  Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles.

Authors:  Brian T Luk; Che-Ming Jack Hu; Ronnie H Fang; Diana Dehaini; Cody Carpenter; Weiwei Gao; Liangfang Zhang
Journal:  Nanoscale       Date:  2014-01-27       Impact factor: 7.790

10.  Surface functionalization of gold nanoparticles with red blood cell membranes.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Jing Su; Liangfang Zhang
Journal:  Adv Mater       Date:  2013-05-27       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.